5102
Y. Sun et al. / Tetrahedron 56 (2000) 5093±5103
(m, 9H, ±NH±CH2, ±NH±CH and CH2± of benzyl); 2.1±
1.8 (b, 2H, ±NH±); 1.4±1.1 (m, 15H, methyl). 13C NMR (in
CDCl3): 160.2 (±COO); 144.6 (4 of benzene); 129.5, 128.9
and 128.7 (1,2,3,5,6 of benzene); 61.6 (±CH2CH3); 60.6±
50.4 (±NH±CH2, ±NH±CH); 40.9 (±CH2± of benzyl);
29.3±23.7 (±C(CH3)2, ±C(CH3)3); 14.1 (±CH2CH3). FAB
MS: [M1H]397. Anal. Calcd for C20H32N2O2S2´1/2H2O:
C, 59.26; H, 8.15; N, 6.91. Found: C, 59.47; H, 8.33; N,
6.86.
±N±CH2C±, ±CH2± of benzyl); 32.3, 31.7, (±C(CH3)2);
30.8, 29.0 27.7, 27.0 (±C(CH3)2); FAB. MS:
[M1H1]484. Anal. Calcd for C22H32N2O6S2. 1.5.H2O: C,
51.66; H, 6.85; N, 5.48. Found: C, 51.37; H, 6.34; N, 5.20.
Preliminary experiment about conjugation
About 0.11 g (0.13 mmol) of compound 1 and 11.6 mg
(0.13 mmol) of dl-alanine in of CH2Cl2 (0.5 mL) were
treated with a solution of 26.8 mg (0.13 mmol) of DCC
(N,N0-dicyclohexylcarbodiimide) in 0.5 mL of CH2Cl2.
After 15 min., the conjugated precipitate was ®ltered and
washed with small amount of ethyl acetate. The 13C NMR
of this product shows a benzamide peak at 162 ppm.
6-(p-Carbethoxybenzyl)-3,3,10,10-tetramethyl-1,2-dithia-
5,8-diaza-cyclodecane-N,N0-diacetic acid, di-tert-butyl)
ester (17). A mixture of 0.24 g (0.61 mmol) of compound
16, 0.72 g (3.7 mmol) of t-butyl bromoacetate; 0.25 g
(1.8 mmol) K2CO3 and 0.1 g (0.61 mmol) of KI was
prepared and was stirred at rt for 19 h. It was ®ltered and
washed with CH2Cl2. The ®ltrate and washings were
combined and the solvents and excess BrCH2COO±t-Bu
were removed by distillation under reduced pressure.
After vacuum drying at 1 mmHg/508C for 6 h, 0.45 g of
pale yellow oil was obtained. It was puri®ed with silica
gel 60 and was eluted by benzene and benzene±ethyl
Acknowledgements
This research was supported by the US Public Health
Service, National Cancer Institute, CA-42925 (A. E. M.
and M. J. W.). National Science Foundation Grant
CHE-8705697 supported the purchase of the mass
spectrometers.
1
ether; 0.3 g of pure product was obtained, yield 79%. H
NMR (in CDCl3): 7.97 (d, 2H, 3,5-benzene); 7.26 (d, 2H,
2,6-benzene); 4.36 (quadri, 2H, ±CH2CH3); 4.33.8 and 3.4±
2.8 (m, 9H, ±N±CH2C±, ±N±CH and CH2± of benzyl);
2.2±2.5 (m, 4H, ±CH2±COOt-Bu); 1.5±1.1 (m, 33H,
methyl). 13C NMR (in CDCl3): 171.5 and 170.7 (±CvO
of the ester); 166.6 (CvO± of the benzoate); 145.6 (4 of
benzene); 129.5, 129.4 and 128.3 (1,2,3, 5,6 of benzene);
80.0 (±CH2± of the acetate); 60.7, 58.8, 56.0, 53.7, 50.1
(±CH2CH3, ±N±CH2CH±, ±N±CH2C±, ±CH2± of benzyl);
38.3 (±C(CH3)3); 33.2 and 32.3 (±C(CH3)2); 28.1
(±C(CH3)3); 27.0 and 25.3 (±C(CH3)2); 14.3 (±CH2CH3).
FAB. MS: [M1H1]625. Anal. Calcd for C32H52N2O6S2´1/
2H2O: C, 60.06; H, 8.37; N, 4.42. Found: C, 60.23; H, 8.36;
N, 4.26.
References
1. Sundberg, M. W.; Meares, C. F.; Goodwin, D. A. J. Med. Chem.
1974, 17, 1304±1308.
2. Yeh, S. M.; Sherman, D. G.; Meares, C. F. Anal. Biochem.
1979, 152±159.
3. DeRiemer, L. H.; Meares, C. F.; Goodwin, D. A.; Diamanti, C. I.
J. Label. Compd. Radiopharm. 1980, 18, 1517±1534.
4. Altman, J.; Shoef, N.; Wilchek, M.; Warshawsky, A. J. Chem.
Soc. Perkin Trans. 1 1984, 59±62.
5. Brechbiel, M. W.; Gansow, O. A.; Atcher, R. W.; Schlom, J.;
Esteban, J.; Simpson, D.; Colcher, D. Inorg. Chem. 1986, 25 (16),
2772±2781.
6-( p-Carboxybenzyl)-3,3,10,10-tetramethyl-1,2-dithia-5,
8-diaza-cyclodecane-N,N0-diacetic acid (18). In an ice-
water bath, 0.35 mL of water was added to a suspension
of 7.85 g (0.070 mmol) of K1OC(CH3)32 in 77 mL of
ethyl ether. A solution of 1.7 g (2.7 mmol) of compound
17 in 50 mL of ethyl ether was added dropwise. This reac-
tion mixture was stirred at rt for 27 h. After 10 mL of water
was added, it became two phases. The yellow aqueous phase
was separated and the ether phase was washed with water.
The aqueous phase and washings were combined and
neutralized with 6 M HCl until pH2±3. A large amount
of yellow precipitate was obtained. It was taken out, washed
and redissolved in dilute KOH aqueous solution and repre-
cipitated with dilute HCl at pH1.8. After vacuum drying,
0.92 g pale yellow powder-like product was obtained;
another 0.1 g pure product was obtained from the ®ltrate;
6. Moi, Min K.; Meares, C. F.; DeNardo, S. J. J. Am. Chem. Soc.
1988, 100, 6266±6267.
7. Studer, M.; Meares, C. F. Bioconjugate Chem. 1992, 3, 539±
563.
8. Cox, J. P. L.; Craig, A. S.; Helps, I. M.; Jankowski, K. J.;
Parker, D.; Eaton, M. A. W.; Millican, A. T.; Millar, K.; Beeley,
N. R. A.; Boyce, B. A. J. Chem. Soc. Perkin Trans. 1 1990, 2567±
2576.
9. Baidoo, K. E.; Lever, S. Z. Bioconjugate Chem. 1990, 1, 132±
137.
10. Rao, T. N.; Brixner, D. I.; Srinivasan, A.; Kasina, S.;
Vanderheyden, J. L.; Wester, D. W.; Fritzberg, A. R. Appl. Radiat.
Isot. 1991, 42, 525±530.
11. Gestin, J. F.; Benoist, E.; Loussouarn, A.; Mishra, A. K.;
Faivre-Chauvet, A.; Chatal, J. F. New J. Chem. 1997, 21, 1021±
1026.
1
total yield 1.02 g, 77%. H NMR (in D2O±NaOD; CH3OD
12. Harris, W. R.; Chen, Y.; Wein, K. Inorg. Chem. 1994, 33,
4991±4998.
as internal standard: 3.34 ppm; pD12): 7.81 (d, 2H, 3,5-
benzene); 7.23 (d, 2H, 2,6-benzene); 3.4±2.1 (m, 13H, ±N±
CH2±, ±N±CH and CH2± of benzyl); 1.4±1.2 (m, 12H,
methyl). 13C NMR (in D2O±NaOD; CH3OD as internal
standard: 49.0 ppm; pD12): 179.4 and 179.0 (±CvO of
the di-acetate); 174.9 (±CvO± of the benzoate); 143.7 (4 of
benzene); 134.4, 129.5, 129.4 and 128.9 (1,2,3,5,6 of ben-
zene); 62.7, 53.2, 51.8, 51.1, 50.8 (CH2CH3, ±N±CH2CH±,
13. Smith, R. M.; Martell, A. E.; Motekaitis, R. J. Critical Stability
Constants Database 46, Version 5 NIST: Gaithersburg, MD, 1993.
14. Sun, Y.; Motekaitis, R. J.; Martell, A. E.; Welch, M. J.
J. Coord. Chem. 1995, 36, 235±246.
15. Sun, Y.; Anderson, C. J.; Pajeau, T. S.; Reichert, D. E.;
Hancock, R. D.; Motekaitis, R. J.; Martell, A. E.; Welch, M. J.
J. Med. Chem. 1996, 39, 458±470.